IL-17A in Human Liver: Significant Source of Inflammation and Trigger of Liver Fibrosis Initiation
Authors:
- Daria Kartasheva-EbertzDKDaria Kartasheva-Ebertz
- Jesintha GastonJGJesintha Gaston
- Loriane Lair-MehiriLLLoriane Lair-Mehiri
- Estelle MottezEMEstelle Mottez
- Tan-Phuc BuivanTBTan-Phuc Buivan
- Pierre-Philippe MassaultPMPierre-Philippe Massault
- Olivier ScattonOSOlivier Scatton
- Sebastien GaujouxSGSebastien Gaujoux
- Jean-Christophe VaillantJVJean-Christophe Vaillant
- Stanislas PolSPStanislas Pol
- Sylvie LagayeSLSylvie Lagaye
Open Access
- 29 August 2022
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (17) , 9773
Abstract
IL-17A is considered to guide liver inflammation and fibrosis. From twenty-two human liver samples of different fibrosis stages (F0 to F4), IL-17A, IL-22, and TGFβ1 protein expression in liver tissue lysates were analyzed. Ten paired samples of liver tissue (F0–F1 stage) and blood from the same patient were used to analyze intrahepatic and blood T-lymphoid IL-17A+ cells by flow cytometry. The analyses have been performed regardless of pathology, considering the stage of fibrosis. Human liver tissue was used for the primary human liver slice cultures, followed by subsequent cytokine stimulation and fibrotic markers’ analysis by ELISA. IL-17A production in human liver tissue was significantly higher in the early fibrotic stage compared with the advanced stage. Th17 T cells and, to a lesser extent, MAIT cells were the main sources of IL-17A in both compartments, the liver and the blood. Moreover, the presence of liver Th17IL-17A+INFγ+ cells was detected in the liver. IL-17A stimulation of human liver slice culture increased the expression of profibrotic and pro-inflammatory markers. IL-17A, secreted by Th17 and MAIT cells in the liver, triggered fibrosis by inducing the expression of IL-6 and profibrotic markers and could be a target for antifibrotic treatment. Further amplitude studies are needed to confirm the current results.Keywords
Funding Information
- Assistance publique-Hôpitaux de Paris (4507091642 CCH, U1223-P-A1L4-SE-U1223SE19DA-U122319D, R19171DD-RAK19040DDA)
- Institut National de la Santé et de la Recherche Médicale (4507091642 CCH, U1223-P-A1L4-SE-U1223SE19DA-U122319D, R19171DD-RAK19040DDA)
- Institut Pasteur (4507091642 CCH, U1223-P-A1L4-SE-U1223SE19DA-U122319D, R19171DD-RAK19040DDA)
- Groupement des Entreprises Françaises dans la lutte contre le Cancer (4507091642 CCH, U1223-P-A1L4-SE-U1223SE19DA-U122319D, R19171DD-RAK19040DDA)
This publication has 34 references indexed in Scilit:
- Interleukin-17: A Promoter in Colorectal Cancer ProgressionJournal of Immunology Research, 2013
- Interleukin-17 Signaling in Inflammatory, Kupffer Cells, and Hepatic Stellate Cells Exacerbates Liver Fibrosis in MiceGastroenterology, 2012
- Myofibroblasts revert to an inactive phenotype during regression of liver fibrosisProceedings of the National Academy of Sciences, 2012
- Interleukin-22 induces hepatic stellate cell senescence and restricts liver fibrosis in miceHepatology, 2012
- Autophagy Releases Lipid That Promotes Fibrogenesis by Activated Hepatic Stellate Cells in Mice and in Human TissuesGastroenterology, 2012
- Efficient replication of primary or culture hepatitis C virus isolates in human liver slices: A relevant ex vivo model of liver infectionHepatology, 2012
- Protective Role of Interleukin-17 in Murine NKT Cell-Driven Acute Experimental HepatitisThe American Journal of Pathology, 2010
- Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the LiverPhysiological Reviews, 2008
- Interleukin 17–producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineagesNature Immunology, 2005
- An Algorithm for the Grading of Activity in Chronic Hepatitis CHepatology, 1996